Variants in the CDKN2B and RTEL1 regions are associated with high-grade glioma susceptibility

Margaret Wrensch, Robert B. Jenkins, Jeffrey S. Chang, Ru Fang Yeh, Yuanyuan Xiao, Paul A. Decker, Karla V. Ballman, Mitchel Berger, Jan C. Buckner, Susan Chang, Caterina Giannini, Chandralekha Halder, Thomas M. Kollmeyer, Matthew L. Kosel, Daniel H. Lachance, Lucie McCoy, Brian P. O'Neill, Joe Patoka, Alexander R. Pico, Michael PradosCharles Quesenberry, Terri Rice, Amanda L. Rynearson, Ivan Smirnov, Tarik Tihan, Joe Wiemels, Ping Yang, John K. Wiencke

Research output: Contribution to journalArticlepeer-review

387 Scopus citations

Fingerprint

Dive into the research topics of 'Variants in the CDKN2B and RTEL1 regions are associated with high-grade glioma susceptibility'. Together they form a unique fingerprint.

Medicine & Life Sciences